ArticleRheumatology advances in practice2025

Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis.

Hajime Yoshifuji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.